Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Annoroad, Illumina partner on reproductive health
August 2015
by  |  Email the author
EDIT CONNECT

SHARING OPTIONS:

BEIJING & SAN DIEGO—A new agreement has been announced between Annoroad and Illumina Inc. for the joint development of advanced clinical applications for reproductive health based on next-generation sequencing (NGS) technology. The companies will collaborate to develop a user-friendly prenatal DNA diagnostic system for the Chinese market, with Annoroad providing its nucleic acid extraction, library preparation and data analysis software and Illumina providing NGS instrument components and related reagents.
 
“Illumina is very excited to collaborate with Annoroad to increase access to reproductive health solutions in China,” Tristan Orpin, senior vice president and general manager of Illumina’s Reproductive and Genetic Health business, commented in a press release. “We are committed to partnering with Chinese companies who share our vision of improving human health by unlocking the power of the genome.”
 
Code:

Back



PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.